pharmaceutical investing Trevena announces successful completion of Phase 1 study of TRV250 for acute migraine
Government approvals secured for the use of Galidesivir as a treatment for Bundibugyo Ebola epidemic in Africa
Alvopetro Announces June Sales Volumes, an Operational Update and Quarterly Natural Gas Pricing Update
